{
    "profile_id": "lidiadaszkiewicz",
    "first_name": "Lidia",
    "last_name": "Daszkiewicz, PhD",
    "sub_title": "Enabling immunotherapy developers to bring C word to cancer patients",
    "profile_picture": "https://media.licdn.com/dms/image/C4E03AQEKaqMO3oSHVQ/profile-displayphoto-shrink_800_800/0/1656169071487?e=1701302400&v=beta&t=aG471BKPnePL6NhocPOT5xzTSCzXj09woBHgeoynSyI",
    "background_image": "https://media.licdn.com/dms/image/C5616AQFYirM4YH7OeA/profile-displaybackgroundimage-shrink_350_1400/0/1621328762899?e=1701302400&v=beta&t=I_CKybwCroO2kAyvi7WWRP8SioZ-4y2c2IXoD79i-fQ",
    "profile_type": "personal",
    "entity_urn": "ACoAAAvgz9gByWyaQTJQ_PnEeXEuDSVz6cZiSxg",
    "object_urn": 199282648,
    "birth_date": null,
    "summary": "BIOSCIENCE & BIOBUSINESS PROFESSIONAL\nA highly adaptable and innovative product owner and business developer, specialising in immunology and immuno-oncology research. Proficient at directing all aspects of programme, operational, marketing, recruitment, and people management activities for major research facilities. Expertise in driving business-critical transformation across programmes, coordinating cross-functional staff, and facilitating pioneering commercial strategies.\n                                                                         \nSkilled in internal and external stakeholder engagement, providing mentorship to staff and utilising extensive technical and analytical knowledge to establish communication networks between parties.\n                                                                         \nAdept at translating specialist scientific ability into tangible commercial benefits, including attaining multiple commercial contracts and R&D grants for leading biotechnology company.\n                                                                       \nContact me at lidia.daszkiewicz@hotmail.com to discuss opportunities.\n",
    "location": {
        "country": "Netherlands",
        "short": "The Hague, South Holland",
        "city": "The Hague",
        "state": "South Holland",
        "default": "The Hague, South Holland, Netherlands"
    },
    "premium": false,
    "influencer": false,
    "treasury_media": [],
    "languages": {
        "primary_locale": {
            "country": "US",
            "language": "en"
        },
        "supported_locales": [
            {
                "country": "US",
                "language": "en"
            },
            {
                "country": "ES",
                "language": "es"
            }
        ],
        "profile_languages": [
            {
                "name": "Dutch (Beginner)",
                "proficiency": null
            },
            {
                "name": "English (Fluent)",
                "proficiency": null
            },
            {
                "name": "Polish (Native)",
                "proficiency": null
            },
            {
                "name": "Russian (Intermediate)",
                "proficiency": null
            },
            {
                "name": "Spanish (Fluent)",
                "proficiency": null
            }
        ]
    },
    "industry": "Biotechnology",
    "education": [
        {
            "date": {
                "start": {
                    "month": null,
                    "day": null,
                    "year": 2019
                },
                "end": {
                    "month": null,
                    "day": null,
                    "year": 2019
                }
            },
            "school": {
                "name": "Talent Accelerator Programme for BioBusiness (TAP BioBusiness)",
                "logo": null,
                "url": null
            },
            "degree_name": null,
            "field_of_study": null,
            "grade": null
        },
        {
            "date": {
                "start": {
                    "month": null,
                    "day": null,
                    "year": 2007
                },
                "end": {
                    "month": null,
                    "day": null,
                    "year": 2012
                }
            },
            "school": {
                "name": "Universidad Aut\u00f3noma de Madrid",
                "logo": "https://media.licdn.com/dms/image/C4D0BAQEvmivAb4xnSA/company-logo_400_400/0/1564727866871?e=1703721600&v=beta&t=NPypvDdj87iuwFB_qxy1EvJO9OecumPtzuis85fQSIk",
                "url": "https://www.linkedin.com/school/universidad-autonoma-de-madrid/"
            },
            "degree_name": "PhD in Molecular Biology",
            "field_of_study": "Immunology and Oncology",
            "grade": null
        },
        {
            "date": {
                "start": {
                    "month": null,
                    "day": null,
                    "year": 2005
                },
                "end": {
                    "month": null,
                    "day": null,
                    "year": 2006
                }
            },
            "school": {
                "name": "Ghent University",
                "logo": "https://media.licdn.com/dms/image/C560BAQFWIve9JLlDZQ/company-logo_400_400/0/1583767272648?e=1703721600&v=beta&t=ARafHll8EI3PkwrBn-T8aSJpSJL_Z_-XhCcjo3SDSKM",
                "url": "https://www.linkedin.com/school/ghent-university/"
            },
            "degree_name": "Master in Biotechnology",
            "field_of_study": "Biomedical Research",
            "grade": null
        },
        {
            "date": {
                "start": {
                    "month": null,
                    "day": null,
                    "year": 2001
                },
                "end": {
                    "month": null,
                    "day": null,
                    "year": 2006
                }
            },
            "school": {
                "name": "University of Life Sciences, Lublin, Poland",
                "logo": null,
                "url": null
            },
            "degree_name": "Licentiate in Biotechnology",
            "field_of_study": "Biotechnology",
            "grade": null
        }
    ],
    "patents": [],
    "awards": [
        {
            "title": "Honors (cum laude) for the PhD defense",
            "description": null,
            "issuer": "Universidad Aut\u00f3noma de Madrid",
            "date": {
                "month": 2,
                "day": null,
                "year": 2012
            }
        },
        {
            "title": "PhD fellowship",
            "description": null,
            "issuer": "Spanish Ministry of Education FPU (Formaci\u00f3n del Profesorado Universitario)",
            "date": {
                "month": 2,
                "day": null,
                "year": 2007
            }
        },
        {
            "title": "Diploma for good academic results",
            "description": null,
            "issuer": "Speaker of the Senate, Lublin, Poland",
            "date": {
                "month": 6,
                "day": null,
                "year": 2006
            }
        },
        {
            "title": "Diploma for high grades",
            "description": null,
            "issuer": "Governor of Lublin, Poland",
            "date": {
                "month": 6,
                "day": null,
                "year": 2006
            }
        },
        {
            "title": "Diploma for outstanding Master Thesis",
            "description": null,
            "issuer": "Dean of Biotechnology and Food Sciences Faculty, University of Agriculture, Lublin, Poland",
            "date": {
                "month": 6,
                "day": null,
                "year": 2006
            }
        },
        {
            "title": "Diploma for outstanding student",
            "description": null,
            "issuer": "Dean of Biotechnology and Food Sciences Faculty, University of Agriculture Lublin, Poland",
            "date": {
                "month": 6,
                "day": null,
                "year": 2006
            }
        },
        {
            "title": "Master degree fellowship",
            "description": null,
            "issuer": "University of Agriculture in Lublin, Poland",
            "date": {
                "month": 10,
                "day": null,
                "year": 2005
            }
        },
        {
            "title": "Fellowship for Academic Excellence",
            "description": "Renewed annually (to 2005)",
            "issuer": "University of Agriculture in Lublin, Poland",
            "date": {
                "month": null,
                "day": null,
                "year": 2001
            }
        }
    ],
    "certifications": [],
    "organizations": [],
    "projects": [],
    "publications": [
        {
            "name": "On How Fas Apoptosis-Independent Pathways Drive T Cell Hyperproliferation and Lymphadenopathy in lpr Mice.",
            "publisher": "Frontiers in Immunology",
            "url": "http://journal.frontiersin.org/article/10.3389/fimmu.2017.00237/full",
            "date": {
                "month": null,
                "day": null,
                "year": 2017
            },
            "authors": [
                {
                    "type": "standardizedContributor",
                    "first_name": "Lidia",
                    "last_name": "Daszkiewicz, PhD",
                    "name": null,
                    "headline": "Enabling immunotherapy developers to bring C word to cancer patients"
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Cristina",
                    "last_name": "Vazquez Mateo, PhD",
                    "name": null,
                    "headline": "Scientific Director of Clinical Research at EMD Serono, Inc."
                }
            ]
        },
        {
            "name": "Intralymphatic mRNA vaccine induces CD8 T-cell responses that inhibit the growth of mucosally located tumours.",
            "publisher": "nature publishing group",
            "url": "http://www.ncbi.nlm.nih.gov/pubmed/26931556",
            "date": {
                "month": null,
                "day": null,
                "year": 2016
            },
            "authors": [
                {
                    "type": "standardizedContributor",
                    "first_name": "Lidia",
                    "last_name": "Daszkiewicz, PhD",
                    "name": null,
                    "headline": "Enabling immunotherapy developers to bring C word to cancer patients"
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Lukas",
                    "last_name": "Bialkowski",
                    "name": null,
                    "headline": "Connecting Biotech & Pharma with the Right Technologies"
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Kevin",
                    "last_name": "Van der Jeught",
                    "name": null,
                    "headline": "Assistant Professor"
                }
            ]
        },
        {
            "name": "Distinct p21 requirements for regulating normal and self-reactive T cells through IFN-\u03b3 production.",
            "publisher": "nature publishing group",
            "url": "http://www.nature.com/srep/2015/150109/srep07691/full/srep07691.html",
            "date": {
                "month": null,
                "day": null,
                "year": 2015
            },
            "authors": [
                {
                    "type": "standardizedContributor",
                    "first_name": "Lidia",
                    "last_name": "Daszkiewicz, PhD",
                    "name": null,
                    "headline": "Enabling immunotherapy developers to bring C word to cancer patients"
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Cristina",
                    "last_name": "Vazquez Mateo, PhD",
                    "name": null,
                    "headline": "Scientific Director of Clinical Research at EMD Serono, Inc."
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Gorjana",
                    "last_name": "Rackov",
                    "name": null,
                    "headline": "BioMed X Institute | Spanish National Centre for Biotechnology CNB-CSIC"
                }
            ]
        },
        {
            "name": "Targeting the tumor microenvironment to enhance antitumor immune responses",
            "publisher": "Oncotarget",
            "url": null,
            "date": {
                "month": null,
                "day": null,
                "year": 2014
            },
            "authors": [
                {
                    "type": "standardizedContributor",
                    "first_name": "Lidia",
                    "last_name": "Daszkiewicz, PhD",
                    "name": null,
                    "headline": "Enabling immunotherapy developers to bring C word to cancer patients"
                },
                {
                    "type": "nonStandardizedContributor",
                    "first_name": null,
                    "last_name": null,
                    "name": "Kevin Van der Jeught",
                    "headline": null
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Lukas",
                    "last_name": "Bialkowski",
                    "name": null,
                    "headline": "Connecting Biotech & Pharma with the Right Technologies"
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Katrijn",
                    "last_name": "Broos",
                    "name": null,
                    "headline": "Scientist bij Biocartis"
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Cleo",
                    "last_name": "Goyvaerts",
                    "name": null,
                    "headline": "Assistant Professor - Biomedical Sciences - Antitumor immunotherapy for lung cancer - 3D tissue modelling"
                },
                {
                    "type": "nonStandardizedContributor",
                    "first_name": null,
                    "last_name": null,
                    "name": "Dries Renmans",
                    "headline": null
                },
                {
                    "type": "nonStandardizedContributor",
                    "first_name": null,
                    "last_name": null,
                    "name": "Sandra Van Lint",
                    "headline": null
                },
                {
                    "type": "nonStandardizedContributor",
                    "first_name": null,
                    "last_name": null,
                    "name": "Carlo Heirman",
                    "headline": null
                },
                {
                    "type": "nonStandardizedContributor",
                    "first_name": null,
                    "last_name": null,
                    "name": "Kris Thielemans",
                    "headline": null
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Karine",
                    "last_name": "Breckpot",
                    "name": null,
                    "headline": "Professor at Vrije Universiteit Brussel"
                }
            ]
        },
        {
            "name": "Intratumoral administration of mRNA encoding a fusokine consisting of IFN-\u03b2 and the ectodomain of the TGF-\u03b2 receptor II potentiates antitumor immunity.",
            "publisher": "Oncotarget",
            "url": null,
            "date": {
                "month": null,
                "day": null,
                "year": 2014
            },
            "authors": [
                {
                    "type": "standardizedContributor",
                    "first_name": "Lidia",
                    "last_name": "Daszkiewicz, PhD",
                    "name": null,
                    "headline": "Enabling immunotherapy developers to bring C word to cancer patients"
                },
                {
                    "type": "nonStandardizedContributor",
                    "first_name": null,
                    "last_name": null,
                    "name": "Kevin Van der Jeught",
                    "headline": null
                },
                {
                    "type": "nonStandardizedContributor",
                    "first_name": null,
                    "last_name": null,
                    "name": "Patrick Joe",
                    "headline": null
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Lukas",
                    "last_name": "Bialkowski",
                    "name": null,
                    "headline": "Connecting Biotech & Pharma with the Right Technologies"
                },
                {
                    "type": "nonStandardizedContributor",
                    "first_name": null,
                    "last_name": null,
                    "name": "Carlo Heriman",
                    "headline": null
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Therese",
                    "last_name": "Liechtenstein",
                    "name": null,
                    "headline": "Investment Director at M Ventures | Biotech Investments"
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "David",
                    "last_name": "Escors Murugarren",
                    "name": null,
                    "headline": "Miguel Servet Fellow at Fundacion Miguel Servet"
                },
                {
                    "type": "nonStandardizedContributor",
                    "first_name": null,
                    "last_name": null,
                    "name": "Kris Thielemans",
                    "headline": null
                },
                {
                    "type": "standardizedContributor",
                    "first_name": "Karine",
                    "last_name": "Breckpot",
                    "name": null,
                    "headline": "Professor at Vrije Universiteit Brussel"
                }
            ]
        }
    ],
    "courses": [
        {
            "name": "Internship, Polish Academy of Sciences (PAN), Warsaw, Poland",
            "number": "Institute of Genetics and"
        },
        {
            "name": "Internship, Regional Hospital in \u0141uk\u00f3w, Poland",
            "number": "Laboratory Department,"
        },
        {
            "name": "Summer internship, Hampshire, England",
            "number": "Fragaria ananassa farm"
        }
    ],
    "test_scores": [],
    "position_groups": [
        {
            "company": {
                "id": 12969,
                "name": "Genmab",
                "logo": "https://media.licdn.com/dms/image/C4E0BAQEHX8of79MCjQ/company-logo_400_400/0/1660322057913?e=1703721600&v=beta&t=BVf_3DU0Pkhbh31YQ3MtelkErPCIRy7ZlOT6f6n0xP0",
                "url": "https://www.linkedin.com/company/genmab/",
                "employees": {
                    "start": 1001,
                    "end": 5000
                }
            },
            "date": {
                "start": {
                    "month": 4,
                    "day": null,
                    "year": 2022
                },
                "end": {
                    "month": null,
                    "day": null,
                    "year": null
                }
            },
            "profile_positions": [
                {
                    "location": "Utrecht, Netherlands",
                    "date": {
                        "start": {
                            "month": 1,
                            "day": null,
                            "year": 2023
                        },
                        "end": {
                            "month": null,
                            "day": null,
                            "year": null
                        }
                    },
                    "company": "Genmab",
                    "description": null,
                    "title": "Translational Research Lead",
                    "employment_type": "Full-time"
                },
                {
                    "location": "Utrecht, Netherlands",
                    "date": {
                        "start": {
                            "month": 4,
                            "day": null,
                            "year": 2022
                        },
                        "end": {
                            "month": 1,
                            "day": null,
                            "year": 2023
                        }
                    },
                    "company": "Genmab",
                    "description": "Creating win-win relationships that leverage Genmab\u2019s and its Partners\u2019 expertise and capabilities combined with team efficiency and cost-effectiveness. Genmab is an international biotechnology company with a core purpose to improve the lives of people with cancer. To develop and deliver novel therapies to patients, Genmab has formed 20+ strategic partnerships with biotechnology and pharmaceutical companies. Genmab\u2019s proprietary pipeline includes bispecific T-cell engagers, next-generation immune checkpoint modulators, effector function enhanced antibodies and antibody-drug conjugates. \nI am responsible for managing and optimizing the value of Genmab\u2019s global pharmaceutical partner alliances, which include:\n\u2022\tDevelopment of joint alliance vision, goals, and guiding principles.\n\u2022\tOverseeing the governance of partnership agreements.\n\u2022\tEnsuring joint strategy implementation in alignment with alliance operating principles and product strategy & tactical plans per local brand plan to obtain alignment from partners. \n\u2022\tManaging long term relationships between Genmab and our global corporate partners by establishing a high level of trust and collaboration.   \n\u2022\tEnsuring smooth execution of all alliance related activities and issue resolution between internal stakeholders and partners.\n\u2022\tDriving communication and facilitating decision making by capturing local specific needs to be reflected to the best interests for both global & local. \n\u2022\tTracking and communicating key milestones, financial transactions, and progress reports to assure compliance with stated plans.  \n\u2022\tActing as an internal expert on partner companies by building expertise about partner, including company organization/leadership, strategies, financials, priorities, etc. \n\u2022\tWorking with Business Development on new deal negotiations, including governance structure and partnership launch preparation.\n\u2022\tDetermining key success factors and metrics for measuring alliance health and success.",
                    "title": "Global Alliance Management",
                    "employment_type": "Full-time"
                }
            ]
        },
        {
            "company": {
                "id": 693709,
                "name": "Crown Bioscience",
                "logo": "https://media.licdn.com/dms/image/D4E0BAQFlo2EmCrFPrA/company-logo_400_400/0/1688148653098?e=1703721600&v=beta&t=3eU_VrWy4LUXxMXoq5D31zeyQHzxaM4_0IQeTgMgN9c",
                "url": "https://www.linkedin.com/company/crown-bioscience-inc-/",
                "employees": {
                    "start": 1001,
                    "end": 5000
                }
            },
            "date": {
                "start": {
                    "month": 4,
                    "day": null,
                    "year": 2021
                },
                "end": {
                    "month": 4,
                    "day": null,
                    "year": 2022
                }
            },
            "profile_positions": [
                {
                    "location": "Leiden, South Holland, Netherlands",
                    "date": {
                        "start": {
                            "month": 4,
                            "day": null,
                            "year": 2021
                        },
                        "end": {
                            "month": 4,
                            "day": null,
                            "year": 2022
                        }
                    },
                    "company": "Crown Bioscience",
                    "description": "Leading Immuno-Oncology in vitro activities of a global contract research organization (CRO) providing preclinical and translational platforms to advance oncology, immuno-oncology, and immune-mediated inflammatory diseases. Crown Bioscience, a JSR Life Sciences company, is the only preclinical CRO to provide tumor organoid services utilizing HUB technology and has the world\u2019s largest commercially available PDX collection. Crown Bioscience helps deliver superior drug candidates to ensure that patients get the right treatment at the right time. I have contributed to advancing development of immunotherapy candidates of our customers by:\n\u2022\tDefining and directing the execution of the commercial strategy\n\u2022\tManaging Immuno-Oncology Department \n\u2022\tIntegrating portfolios across the different sites, \n\u2022\tOverseeing marketing assets and market positioning. \n\u2022\tDirecting R&D efforts to make sure they are aligned with company vision.\n\u2022\tIntegrating systems and procedures to ensure smooth transitioning after OcellO acquisition.",
                    "title": "Senior Director Immuno-Oncology",
                    "employment_type": "Full-time"
                }
            ]
        },
        {
            "company": {
                "id": null,
                "name": "OcellO",
                "logo": null,
                "url": null,
                "employees": {
                    "start": null,
                    "end": null
                }
            },
            "date": {
                "start": {
                    "month": 11,
                    "day": null,
                    "year": 2015
                },
                "end": {
                    "month": 4,
                    "day": null,
                    "year": 2021
                }
            },
            "profile_positions": [
                {
                    "location": "Leiden, South Holland, Netherlands",
                    "date": {
                        "start": {
                            "month": 10,
                            "day": null,
                            "year": 2019
                        },
                        "end": {
                            "month": 4,
                            "day": null,
                            "year": 2021
                        }
                    },
                    "company": "OcellO",
                    "description": "Enabling definition and realisation of corporate strategy for Contract Research Organisation (CRO), providing drug testing on 3D cultured human tissues and pioneering high-content 3D imaging platform. Designed and directed delivery of account portfolio, overseeing market positioning and optimising capacity and productivity as mentor for colleagues, supporting staff development and ensuring understanding of company vision. Enhanced and established programme governance, introducing comprehensive IP protection policy and performing gap analysis to improve practices. Represented organisation at global meetings and conferences, contributing to industry visibility.\n\u2022  Effectively doubled size of immuno-oncology department, directing team and enabling smooth transition.\n\u2022  Facilitated creation of communication channels with multiple leading pharmaceutical companies, developing strong networks with key stakeholders, including biotech companies and academic institutions.\n\u2022  Supported the acquisition by Crown Bioscience Inc. by managing parts of the due diligence and post-merger integration process.",
                    "title": "Senior Director Immuno-Oncology",
                    "employment_type": "Full-time"
                },
                {
                    "location": "Leiden, The Netherlands",
                    "date": {
                        "start": {
                            "month": 11,
                            "day": null,
                            "year": 2015
                        },
                        "end": {
                            "month": 10,
                            "day": null,
                            "year": 2019
                        }
                    },
                    "company": "OcellO",
                    "description": "Engineered developmental strategic roadmap for immuno-oncology programme, building core technical team and supporting professional growth.  Architected successful design and delivery of innovative biological in vitro models. Coordinated ongoing projects and account portfolio, ensuring alignment with wider industry trends and technologies. Orchestrated connections within immuno-oncology and oncology drug development field, identifying potential opportunities for organisation. Acted as liaison between technical teams and customers, recognising customer requirements and embedding needs in creation of cost-effective programming. Devised promotional materials and presentations to streamline scientific content for all stakeholders.\n\u2022\tSecured commercial contracts for testing immunotherapies on proprietary screening platform.\n\u2022\tIncreased website traffic via rebranding of organization and launch of lead marketing campaign.",
                    "title": "Head of Immuno-Oncology",
                    "employment_type": "Full-time"
                }
            ]
        },
        {
            "company": {
                "id": 10530088,
                "name": "eTheRNA Immunotherapies",
                "logo": "https://media.licdn.com/dms/image/D4E0BAQHO5tCJUt1AWA/company-logo_400_400/0/1692206811343?e=1703721600&v=beta&t=QUw3wVSOw5ON5Run1QsciNAtc7_fzxQu3jfORr2Wt_k",
                "url": "https://www.linkedin.com/company/etherna-engineering-rna/",
                "employees": {
                    "start": 51,
                    "end": 200
                }
            },
            "date": {
                "start": {
                    "month": 7,
                    "day": null,
                    "year": 2014
                },
                "end": {
                    "month": 10,
                    "day": null,
                    "year": 2015
                }
            },
            "profile_positions": [
                {
                    "location": "Brussels Area, Belgium",
                    "date": {
                        "start": {
                            "month": 7,
                            "day": null,
                            "year": 2014
                        },
                        "end": {
                            "month": 10,
                            "day": null,
                            "year": 2015
                        }
                    },
                    "company": "eTheRNA",
                    "description": "Oversaw completion of technology transition from lab to spin-off for biotech company developing novel mRNA-based immunotherapies to target cancer and infectious diseases. Facilitated business-critical developments, enhancing market position in competitive global field. Produced and organised all marketing and communication documentation, preparing investor presentations, composing position papers, and supporting investor roundtable discussions. Devised and supervised delivery of analytical assays for mRNA vaccine (GMP production).\n\u2022\tContributed to securing series-A investment round of \u20ac24m, managing data room for due diligence",
                    "title": "R&D Scientist/Business Developer",
                    "employment_type": "Full-time"
                }
            ]
        },
        {
            "company": {
                "id": 5413,
                "name": "Laboratory for Molecular and Cellular Therapy (LMCT), Vrije Universiteit Brussel",
                "logo": "https://media.licdn.com/dms/image/D560BAQFMfEJK-Rjl9w/company-logo_400_400/0/1685519615117?e=1703721600&v=beta&t=GOAMxx0TnytYquOpAzCy-3JngjbJSRVAMtNW_8-kSM0",
                "url": "https://www.linkedin.com/school/vrije-universiteit-brussel/",
                "employees": {
                    "start": 1001,
                    "end": 5000
                }
            },
            "date": {
                "start": {
                    "month": 7,
                    "day": null,
                    "year": 2013
                },
                "end": {
                    "month": 7,
                    "day": null,
                    "year": 2014
                }
            },
            "profile_positions": [
                {
                    "location": "Brussels Area, Belgium",
                    "date": {
                        "start": {
                            "month": 7,
                            "day": null,
                            "year": 2013
                        },
                        "end": {
                            "month": 7,
                            "day": null,
                            "year": 2014
                        }
                    },
                    "company": "Vrije Universiteit Brussel",
                    "description": "Architected strategies and analytical assays to evaluate and enhance mRNA performance in preclinical models, facilitating creation of tumor mRNA-based vaccine to be used as personalized cancer immunotherapy. Supervised research grade mRNA production, optimizing development of in vitro transcription with modified nucleotides and posttranscriptional purification. Supplemented all business enhancement activities for spin-off company, eTheRNA.",
                    "title": "Postdoc",
                    "employment_type": "Full-time"
                }
            ]
        },
        {
            "company": {
                "id": 891859,
                "name": "Spanish National Centre for Biotechnology",
                "logo": "https://media.licdn.com/dms/image/C4D0BAQECjuBVdfUrOw/company-logo_400_400/0/1519914384227?e=1703721600&v=beta&t=0SoB3SGDyTSduEqe4gtGJcjubabWzTucfW1nDY0fxwg",
                "url": "https://www.linkedin.com/company/the-institute-for-construction-science---csic/",
                "employees": {
                    "start": 201,
                    "end": 500
                }
            },
            "date": {
                "start": {
                    "month": 2,
                    "day": null,
                    "year": 2007
                },
                "end": {
                    "month": 7,
                    "day": null,
                    "year": 2012
                }
            },
            "profile_positions": [
                {
                    "location": "Madrid, Spain",
                    "date": {
                        "start": {
                            "month": 2,
                            "day": null,
                            "year": 2007
                        },
                        "end": {
                            "month": 7,
                            "day": null,
                            "year": 2012
                        }
                    },
                    "company": "The Institute for Construction Science - CSIC",
                    "description": "Helmed significant projects within department studying signalling pathways involved in T-cell homeostasis with potential therapeutic value for autoimmune diseases. Identified molecular defects provoking lupus-like disease in mouse models, utilising biochemistry and cell biology to provide potential targets for treatment. Achieved reversal of autoimmune disease in mouse model via genetic manipulation, subsequently creating posters and presentations to share findings. Encouraged cross-departmental collaboration, engaging external parties and training new technicians and students.",
                    "title": "PhD",
                    "employment_type": null
                }
            ]
        },
        {
            "company": {
                "id": 2276,
                "name": "Genentech",
                "logo": "https://media.licdn.com/dms/image/C560BAQHJzRYHjuNbMg/company-logo_400_400/0/1677024169606?e=1703721600&v=beta&t=BigcHFCtDMtVZPLQLge2WqQEb9J80XnlgpqsmGdUWhA",
                "url": "https://www.linkedin.com/company/genentech/",
                "employees": {
                    "start": 10001,
                    "end": null
                }
            },
            "date": {
                "start": {
                    "month": 6,
                    "day": null,
                    "year": 2010
                },
                "end": {
                    "month": 12,
                    "day": null,
                    "year": 2010
                }
            },
            "profile_positions": [
                {
                    "location": "San Francisco, California, USA",
                    "date": {
                        "start": {
                            "month": 6,
                            "day": null,
                            "year": 2010
                        },
                        "end": {
                            "month": 12,
                            "day": null,
                            "year": 2010
                        }
                    },
                    "company": "Genentech",
                    "description": "Contributed to significant breakthrough via creation of system for analysing T-cell receptor internalization in memory T-cells, utilising fluorescence quenching method. Successfully executed technical analysis for leading biotechnology company producing medicines to treat patients with serious medical conditions, including cancer and Alzheimer\u2019s disease. Instituted active communication channels between Spanish National Center for Biotechnology (CNB/CSIC) and Genentech. Effectively expanded scientific networks, encompassing San Francisco technical community",
                    "title": "Visiting Scientist",
                    "employment_type": null
                }
            ]
        },
        {
            "company": {
                "id": 367728,
                "name": "Flanders Interuniversity Institute for Biotechnology (VIB)",
                "logo": "https://media.licdn.com/dms/image/C560BAQH_y3_qv0ngyA/company-logo_400_400/0/1632919533022?e=1703721600&v=beta&t=_TEYBXexK9bUrB5uJOZzQjgf_tE-hNtdQO0B0c55w60",
                "url": "https://www.linkedin.com/company/vib/",
                "employees": {
                    "start": 1001,
                    "end": 5000
                }
            },
            "date": {
                "start": {
                    "month": 10,
                    "day": null,
                    "year": 2005
                },
                "end": {
                    "month": 6,
                    "day": null,
                    "year": 2006
                }
            },
            "profile_positions": [
                {
                    "location": "Gent, Belgium",
                    "date": {
                        "start": {
                            "month": 10,
                            "day": null,
                            "year": 2005
                        },
                        "end": {
                            "month": 6,
                            "day": null,
                            "year": 2006
                        }
                    },
                    "company": "VIB",
                    "description": "Department of Molecular and Biomedical Research, Molecular Signaling and Cell Death Unit \n-\tDetermined the activating factor for caspase-14.\n-\tIsolated huge amount of caspase-14 activating factor from murine epidermis, which allowed detailed studies of caspase-14 function.\n-\tParticipated in the development of strategy to obtain catalytically active caspase14.",
                    "title": "Research Assistant",
                    "employment_type": null
                }
            ]
        },
        {
            "company": {
                "id": 367728,
                "name": "Flanders Interuniversity Institute for Biotechnology (VIB)",
                "logo": "https://media.licdn.com/dms/image/C560BAQH_y3_qv0ngyA/company-logo_400_400/0/1632919533022?e=1703721600&v=beta&t=_TEYBXexK9bUrB5uJOZzQjgf_tE-hNtdQO0B0c55w60",
                "url": "https://www.linkedin.com/company/vib/",
                "employees": {
                    "start": 1001,
                    "end": 5000
                }
            },
            "date": {
                "start": {
                    "month": 3,
                    "day": null,
                    "year": 2005
                },
                "end": {
                    "month": 6,
                    "day": null,
                    "year": 2005
                }
            },
            "profile_positions": [
                {
                    "location": "Gent, Belgium",
                    "date": {
                        "start": {
                            "month": 3,
                            "day": null,
                            "year": 2005
                        },
                        "end": {
                            "month": 6,
                            "day": null,
                            "year": 2005
                        }
                    },
                    "company": "VIB",
                    "description": "Plant System Biology, Cell Cycle Unit\n-\tUsed molecular cloning techniques to clarify the WEE1/CDC25 pathway in plants.",
                    "title": "Research Assistant",
                    "employment_type": null
                }
            ]
        },
        {
            "company": {
                "id": null,
                "name": "Scientific Society of Plant Biologists, University of Life Sciences in Lublin",
                "logo": null,
                "url": null,
                "employees": {
                    "start": null,
                    "end": null
                }
            },
            "date": {
                "start": {
                    "month": 10,
                    "day": null,
                    "year": 2004
                },
                "end": {
                    "month": 2,
                    "day": null,
                    "year": 2005
                }
            },
            "profile_positions": [
                {
                    "location": "Lublin, Poland",
                    "date": {
                        "start": {
                            "month": 10,
                            "day": null,
                            "year": 2004
                        },
                        "end": {
                            "month": 2,
                            "day": null,
                            "year": 2005
                        }
                    },
                    "company": "Scientific Society of Plant Biologists, University of Life Sciences in Lublin",
                    "description": "-\tStudied genetic polymorphism of maize using PCR techniques.",
                    "title": "Researcher",
                    "employment_type": null
                }
            ]
        }
    ],
    "volunteer_experiences": [],
    "skills": [
        "Biotechnology",
        "Immunology",
        "Autoimmune Diseases",
        "Molecular Biology",
        "Oncology",
        "Lifesciences",
        "Cell Signaling",
        "Assay Development",
        "Cell Culture",
        "Flow Cytometry",
        "Confocal Microscopy",
        "Protein Purification",
        "ELISA",
        "PCR",
        "DNA, RNA and protein isolation from animal and plant tissues",
        "Biochemistry",
        "Western Blotting",
        "Electrophoresis on polyacrylamide and agarose gel",
        "Immunoprecipitation of protein complexes",
        "EMSA"
    ],
    "network_info": null,
    "related_profiles": null,
    "contact_info": null
}